These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND IGL AND Diagnosis
13 results:

  • 1. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
    Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
    Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
    [TBL] [Abstract] [Full Text] [Related]  

  • 2.
    Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
    Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Invivoscribe BIOMED-2 primer mixes in B-cell immunoglobulin gene rearrangement studies: experience of a molecular diagnostics laboratory in a major tertiary care center.
    Abbas F; Yazbek SN; Shammaa D; Hoteit R; Fermanian P; Mahfouz R
    Genet Test Mol Biomarkers; 2014 Dec; 18(12):787-90. PubMed ID: 25299065
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Study of immunoglobulin and T-cell receptor gene rearrangements in patients with non-Hodgkin's lymphoma].
    Wu RQ; Qiao C; Tong Y; Ge Z; Zhang JF; Wu YJ; Qiu HR; Wang Z; Liu P
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):10-5. PubMed ID: 22575185
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. BCL2 and MYC dual-hit lymphoma/leukemia.
    Tomita N
    J Clin Exp Hematop; 2011; 51(1):7-12. PubMed ID: 21628855
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.
    Tomita N; Tokunaka M; Nakamura N; Takeuchi K; Koike J; Motomura S; Miyamoto K; Kikuchi A; Hyo R; Yakushijin Y; Masaki Y; Fujii S; Hayashi T; Ishigatsubo Y; Miura I
    Haematologica; 2009 Jul; 94(7):935-43. PubMed ID: 19535347
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The pattern of clonal immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements in Chinese adult acute lymphoblastic leukemia patients.
    Yao L; Chen Z; Cen J; Liang J; Feng Y; He J; Qi X; Shen H
    Leuk Res; 2008 Nov; 32(11):1735-40. PubMed ID: 18456325
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.
    Ghia EM; Jain S; Widhopf GF; Rassenti LZ; Keating MJ; Wierda WG; Gribben JG; Brown JR; Rai KR; Byrd JC; Kay NE; Greaves AW; Kipps TJ
    Blood; 2008 May; 111(10):5101-8. PubMed ID: 18326815
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.
    Jansen MW; Corral L; van der Velden VH; Panzer-Grümayer R; Schrappe M; Schrauder A; Marschalek R; Meyer C; den Boer ML; Hop WJ; Valsecchi MG; Basso G; Biondi A; Pieters R; van Dongen JJ
    Leukemia; 2007 Apr; 21(4):633-41. PubMed ID: 17268512
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Aggressive primary plasma cell leukemia with skin manifestations, trisomy 8 and molecular oligoclonal features.
    Robak T; Urbańska-Rys H; Robak E; Bartkowiak J; Strzelecka B; Biernat W; Kordek R
    Leuk Lymphoma; 2002 May; 43(5):1067-73. PubMed ID: 12148888
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Rearranged immunoglobulin light chain genes as minimal residual disease markers in intermediate- and high-grade malignant B cell non-Hodgkin's lymphoma.
    Hoogeveen-Westerveld M; Hupkes PE; Doekharan D; Dorssers LC; van't Veer MB; van Belzen N
    Leukemia; 1998 Nov; 12(11):1810-6. PubMed ID: 9823958
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Rearrangements of immunoglobulin light chain and heavy chain constant region genes in B-cell malignancies].
    Maruyama F; Ino T; Miyazaki H; Wakita M; Maeda H; Tsuzuki M; Kojima H; Sobue R; Okamoto M; Matsui T
    Rinsho Ketsueki; 1993 Jan; 34(1):1-6. PubMed ID: 8450601
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Malignant lymphoma localized in the abdomen: detection of Ig gene rearrangement from the specimen obtained by percutaneous lymph node biopsy.
    Chou T; Iiri T; Kurasige K; Ito S; Wakabayashi M; Hayashi N; Arakawa M
    Intern Med; 1992 Nov; 31(11):1281-5. PubMed ID: 1295624
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.